DaVita (FRA:TRL) Long-Term Debt: €9,094 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:TRL DaVita Inc FRA:TRL
86 GF Score
Price €206.20
GF Value €152.92
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is DaVita Long-Term Debt?

DaVita FRA:TRL +1.63% 86 Long-Term Debt is €9,094 Mil as of Mar. 2026. GuruFocus rates FRA:TRL with a GF Score™ of 86/100 and a GF Value™ of €152.92 (Significantly Overvalued). The stock has 6 warning signs investors should review.

DaVita's Long-Term Debt for the quarter that ended in Mar. 2026 was €9,094 Mil.

DaVita's quarterly Long-Term Debt increased from Sep. 2025 (€8,677 Mil) to Dec. 2025 (€8,680 Mil) and increased from Dec. 2025 (€8,680 Mil) to Mar. 2026 (€9,094 Mil).

DaVita's annual Long-Term Debt increased from Dec. 2023 (€7,582 Mil) to Dec. 2024 (€8,763 Mil) but then declined from Dec. 2024 (€8,763 Mil) to Dec. 2025 (€8,680 Mil).

DaVita  (FRA:TRL) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

DaVita Long-Term Debt Related Terms

DaVita Long-Term Debt Historical Data

* Premium members only.

The historical data trend for DaVita's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita Long-Term Debt Chart

DaVita Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,725.30 8,205.83 7,582.06 8,762.99 8,680.05

DaVita Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,842.76 8,738.32 8,676.65 8,680.05 9,094.26
FRA:TRL
86GF Score
DaVita Inc FRA:TRL
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of €9,094 Mil mean?
DaVita (FRA:TRL) has a Long-Term Debt of €9,094 Mil as of Mar. 2026.
Is DaVita's Long-Term Debt too high?
DaVita's current Long-Term Debt is €9,094 Mil. Overall, DaVita has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does DaVita's Long-Term Debt compare to THC and EHC?
DaVita's Long-Term Debt of €9,094 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Healthcare Providers & Services company?
A good Long-Term Debt depends on the Healthcare Providers & Services industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. DaVita's current Long-Term Debt is €9,094 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DaVita stock overvalued right now?
Based on GuruFocus' analysis, DaVita (FRA:TRL) is currently considered Significantly Overvalued. The stock's GF Value™ is €152.92, compared to a current price of €206.20 — trading 34.8% above its estimated fair value. The current Long-Term Debt is €9,094 Mil. DaVita's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For DaVita (FRA:TRL), the current Long-Term Debt is €9,094 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DaVita (FRA:TRL) Overvalued in 2026?

Based on GuruFocus' analysis, DaVita stock appears to be overvalued. The current stock price of €206.20 is trading 34.8% above its estimated GF Value™ of €152.92. GuruFocus considers DaVita to be Significantly Overvalued.

Key valuation signals for FRA:TRL:

  • Long-Term Debt: €9,094 Mil
  • GF Value™: €152.92 vs. price of €206.20 (34.8% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the FRA:TRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DaVita Business Description

Address 2000 16th Street, Denver, CO, USA, 80202
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
86GF Score

Get the complete analysis for FRA:TRL

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€206.20
Price
€152.92
GF Value